In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor

Oncogene

Volumn 14, Issue 11, 1997, Pages 1351-1359

  Mohanam, Sanjeeva ^a   Chintala, Shravan K ^a   Go, Yoshinori ^a   Bhattacharya, Anuradha ^a   Venkaiah, Boyapati ^a   Boyd, Douglas ^a   Gokaslan, Ziya L ^a   Sawaya, Raymond ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Glioblastoma; Invasiveness; Plasminogen activators; Receptors

Indexed keywords

COMPLEMENTARY DNA; GELATINASE A; MESSENGER RNA; RECEPTOR PROTEIN; UROKINASE;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL INVASION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIORECEPTOR ASSAY;

EID: 0030899731     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1200963     Document Type: Article

References (45)

1. Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S and Kuwano M. (1994). Clin. Exp. Metastasis, 12, 296-304.
2. Andersson C, Tytell M and Brunso-Bechtold S. (1993). Int. J. Devl. Neurosci., 11, 555-568.
3. Aznavoorian S, Murphy AN, Stetler-Stevenson, WG and Liotta LA (1993). Cancer, 71, 1368-1383.
4. Blasi F. (1988). Fibrinolysis, 2, 73-84.
5. Bianchi E, Cohen RL, Thor AT, Todd RF, Mizukami IF, Lawrence DA, Ljung BM, Shuman MA and Smith HS. (1994). Cancer Res., 54, 861-866.
6. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162: 156-159.
7. Cohen RL, Xi X-P, Crowley CW, Lucas BK, Levinson AD and Shuman MA. (1991). Blood, 78, 479-487.
8. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA and Levinson AD. (1993). Proc. Natl. Acad. Sci. USA, 90, 5021-5025.
9. Danø K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS and Skriver L. (1985). Adv. Cancer Res., 44, 139-266.
10. Danø K, Behrendt N, Brunner N, Ellis V, Ploug M and Pyke C. (1994). Fibrinolysis, 81, 189-203.
11. Ellis V, Pyke C, Eriksen J, Solgerg H and Danø K. (1992). Ann. N. Y. Acad. Sci., 667, 13-31.
12. Gladson CL, Pijuan-Thompson V, Olman MA, Gillespie GY and Yacoub IZ. (1995). Am. J. Pathol. 146, 1150-1160.
13. Kariko K, Kuo A, Boyd DA, Okada SS, Clines DB and Barnathan ES. (1993). Cancer Res., 53, 3109-3117.
14. Kobayashi H, Ohi H, Shinohara H, Fujii T, Schmitt M, Goretzki L, Churcholowski N, Janicke F and Graeff H. (1993). Br. J. Cancer, 67, 537-544.
15. Kook YH, Adamski J, Zelent A and Ossowski L. (1994). EMBO J., 13, 3983-3991.
16. Laemmli UK. (1970). Nature, 227, 680-685.
17. Lampson LA, Wen P, Ramen VA, Morris JH and Sarid JA (1992). Cancer Res., 52, 1018-1025.
18. Langer DJ, Kuo A, Kariko K, Ahuja M, Klugherz BD. Ivanics KM, Hoxie JA, Williams WV, Liang BT, Clines DB and Barnathan ES. (1993). Circulat Res., 730, 330-340.
19. Lund-Johansen M, Bjerkvig R and Rucklidge GJ. (1990) Spheriod culture in Cancer Research. Bjerkvig, R. (ed.) CRC Press, Ann Arbor, pp. 3-18.
20. Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D and Rao JS. (1993). Cancer Res., 53, 4143-4147.
21. Moller LB. (1993). Blood Coagul. Fibrinolysis, 4, 293-303.
22. Nakagawa T, Kubota T, Kabuto M, Sato K, Kawano H, Hayakawa T and Okada Y. (1994). J. Neurosurg., 81, 69-77.
23. Nakajima M, Morakawa K, Fabra A, Bucanna CD and Fidler IJ. (1990). J. Natl. Cancer Inst., 82, 1890-1898.
24. Neuenschwander S, Roberts Jr, CT and LeRoith D. (1995). Endocrinol., 136, 4298-4303.
25. Ossowski L. (1992). Cancer Res., 52, 6754-6760.
26. Pedersen H, Brunner N, Francis D, Osterlind K, Ronee E, Hansen HH, Danø K and Grondahl-Hansen J. (1994). Cancer Res., 54, 4671-4675.
27. Pedersen PH, Marienhagen K, Mork S and Bjerkvig R. (1993). Cancer Res., 53, 5158-5165.
28. Pepper MS, Sappino AP, Stocklin R, Montesano R, Orci L, Vassalli JD. (1993). J. Cell Biol., 122, 673-684.
29. Pollanen J, Stephens RW and Vaheri A. (1991). Adv. Cancer Res., 57, 273-328.
30. Quattrone A, Fibbi G, Anichini E, Pucci M, Zamperini A, Capaccioli S and Rosso MD. (1995a). Cancer Res., 55, 90-95.
31. Quattrone A, Fibbi G, Anichini E, Pucci M, Zamperini A, Capaccioli S and Rosso MD. (1995b). Anticancer Drug Des., 10, 97-102.
32. Ray JM and Stetler-Stevenson WG. (1995). EMBO J., 14, 908-917.
33. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund R, Danø K, Apella E and Blasi F. (1990). EMBO J., 9, 467-474.
34. Russell DS and Rubinstein LJ. (1989). Pathology of Tumors of the Nervous System, Edward Arnold, London, pp. 42-62.
35. Saleh M, Stacker SA and Wilks AF. (1996). Cancer Res., 56, 393-401.
36. Schmitt M, Jänicke F and Graeff H. (1992). Fibrinolysis, 6, 3-26.
37. Scatchard G. (1949). Ann. N.Y. Acad. Sci., 51, 660-665.
38. Stahl A and Mueller BM. (1994). Cancer Res., 54, 3066-3071.
39. Stetler-Stevenson WG, Liotta LA and Kleiner DE. (1993). FASEB J., 7, 1434-1441.
40. Testa JE and Quigly JP. (1990). Cancer Metastasis Rev., 9, 353-367.
41. Towbin H, Staehelin T and Gordon J. (1979). Proc. Natl. Acad. Sci. USA, 76, 4350-4354.
42. Wei Y, Lukashev M, Simon DI, Bodary SC, Rosenberg S, Doyle MV and Chapman HA. (1996). Science, 273, 1551-1555.
43. Wilhelm O, Weidle U and Hohl S. (1994). FEBS Lett., 337, 131-134.
44. Yamamoto M, Sawaya R, Mohanam S, Bindal AK, Bruner JM, Oka K, Rao VH, Tomonaga M, Nicolson GL and Rao JS. (1994a). Cancer Res., 54, 3656-3661.
45. Yamamoto M, Sawaya R, Mohanam S, Rao VH, Bruner JM, Nicolson GL and Rao JS. (1994b). Cancer Res., 54, 5016-5020.